Literature DB >> 34353112

Neuronal CD200 Signaling Is Protective in the Acute Phase of Ischemic Stroke.

Abdullah Al Mamun1, Conelius Ngwa1, Shaohua Qi1, Pedram Honarpisheh1, Saumil Datar1, Romana Sharmeen1, Yan Xu1, Louise D McCullough1, Fudong Liu1.   

Abstract

Background and Purpose: CD200 (cluster of differentiation 200), a highly glycosylated protein primarily expressed on neurons in the central nervous system, binds with its receptor CD200R to form an endogenous inhibitory signal against immune responses. However, little is known about the effect of neuronal CD200 signaling in cerebral ischemia. The aim of this study was to investigate how neuronal CD200 signaling impacts poststroke inflammation and the ischemic injury.
Methods: CD200 tma1lf/fl:Thy1CreER mice were treated with tamoxifen to induce conditional gene knockout (ICKO) of neuronal CD200. The mice were subjected to a 60-minute transient middle cerebral artery occlusion. Stroke outcomes, apoptotic cell death, immune cell infiltration, microglia activation, and other inflammatory profiles were evaluated at 3 and 7 days after stroke.
Results: Infarct volumes were significantly larger, and behavioral deficits more severe in ICKO versus control mice at 3 days after middle cerebral artery occlusion. Terminal deoxynucleotidyl transferase dUTP nick end labeling assay also revealed a significant increase in apoptotic neuronal death in CD200 ICKO mice. An enhancement in lymphocytic infiltration and microglial proinflammatory responses were revealed by flow cytometry at 3 and 7 days after stroke in ICKO mice, accompanied by an increased microglial phagocytosis activity. Plasma proinflammatory cytokine (TNFα [tumor necrosis factor alpha] and IL [interleukin]-1β) levels significantly increased at 3 days, and IL-1β/IL-6 levels increased at 7 days in ICKO versus control animals. ICKO led to significantly lower baseline level of CD200 both in brain and plasma. Conclusions: Neuronal CD200 inhibits proinflammatory responses and is protective against stroke injury.

Entities:  

Keywords:  immunoglobulin; inflammation; ischemic stroke; neurons; neuroprotection

Mesh:

Substances:

Year:  2021        PMID: 34353112      PMCID: PMC8478808          DOI: 10.1161/STROKEAHA.120.032374

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   10.170


  62 in total

Review 1.  TGF-beta: a mobile purveyor of immune privilege.

Authors:  Sharon M Wahl; Jie Wen; Niki Moutsopoulos
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

Review 2.  Breaking or making immunological privilege in the central nervous system: the regulation of immunity by neuropeptides.

Authors:  Emily Reinke; Zsuzsa Fabry
Journal:  Immunol Lett       Date:  2005-12-05       Impact factor: 3.685

Review 3.  Neuro-immune crosstalk in CNS diseases.

Authors:  M Kerschensteiner; E Meinl; R Hohlfeld
Journal:  Neuroscience       Date:  2008-09-13       Impact factor: 3.590

Review 4.  CD200 in asthma.

Authors:  Jean-François Lauzon-Joset; David Marsolais; Éliane Tardif-Pellerin; Dany Patoine; Elyse Y Bissonnette
Journal:  Int J Biochem Cell Biol       Date:  2019-05-08       Impact factor: 5.085

5.  Effects of chronic and acute oestrogen replacement therapy in aged animals after experimental stroke.

Authors:  F Liu; S E Benashski; Y Xu; M Siegel; L D McCullough
Journal:  J Neuroendocrinol       Date:  2012-02       Impact factor: 3.627

6.  Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke.

Authors:  Nicolás Vila; José Castillo; Antonio Dávalos; Anna Esteve; Anna M Planas; Angel Chamorro
Journal:  Stroke       Date:  2003-02-20       Impact factor: 7.914

7.  Serotonergic and cholinergic involvement in habituation of activity and spontaneous alternation of rats in a Y maze.

Authors:  A K Swonger; R H Rech
Journal:  J Comp Physiol Psychol       Date:  1972-12

8.  Soluble CD200 Correlates With Interleukin-6 Levels in Sera of COPD Patients: Potential Implication of the CD200/CD200R Axis in the Disease Course.

Authors:  Priya Sakthivel; Angele Breithaupt; Marcus Gereke; David A Copland; Christian Schulz; Achim D Gruber; Andrew D Dick; Jens Schreiber; Dunja Bruder
Journal:  Lung       Date:  2016-11-18       Impact factor: 2.584

9.  High serum soluble CD200 levels in patients with autosomal dominant polycystic kidney disease.

Authors:  Funda Sari; Saadet Gumuslu; Ramazan Cetinkaya; Metin Sarikaya; Arzu Didem Yalcin
Journal:  J Investig Med       Date:  2017-02-08       Impact factor: 2.895

10.  Inflammatory Responses are Sex Specific in Chronic Hypoxic-Ischemic Encephalopathy.

Authors:  Abdullah Al Mamun; Haifu Yu; Sharmeen Romana; Fudong Liu
Journal:  Cell Transplant       Date:  2018-04-25       Impact factor: 4.064

View more
  1 in total

1.  Regulation of microglial activation in stroke in aged mice: a translational study.

Authors:  Conelius Ngwa; Abdullah Al Mamun; Shaohua Qi; Romana Sharmeen; Yan Xu; Fudong Liu
Journal:  Aging (Albany NY)       Date:  2022-08-12       Impact factor: 5.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.